Citations (90)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Fionnuala Crowley, Michelle Sterpi, Conor Buckley, Lauren Margetich, Shivani Handa & Zach Dovey. (2021) A Review of the Pathophysiological Mechanisms Underlying Castration-resistant Prostate Cancer. Research and Reports in Urology 13, pages 457-472.
Read now
Read now
Pengpeng Wang, Wang Zhang, Lili Wang, Wenquan Liang, Aizhen Cai, Yunhe Gao & Lin Chen. (2020) RCC2 Interacts with Small GTPase RalA and Regulates Cell Proliferation and Motility in Gastric Cancer. OncoTargets and Therapy 13, pages 3093-3103.
Read now
Read now
Yen-Nien Liu, JuanJuan Yin, Ben Barrett, Heather Sheppard-Tillman, Dongmei Li, Orla M. Casey, Lei Fang, Paul G. Hynes, Amir H. Ameri & Kathleen Kelly. (2015) Loss of Androgen-Regulated MicroRNA 1 Activates SRC and Promotes Prostate Cancer Bone Metastasis. Molecular and Cellular Biology 35:11, pages 1940-1951.
Read now
Read now
Michael J Morgan, Graciela Gamez, Christina Menke, Ariel Hernandez, Jacqueline Thorburn, Freddi Gidan, Leah Staskiewicz, Shellie Morgan, Christopher Cummings, Paola Maycotte & Andrew Thorburn. (2014) Regulation of autophagy and chloroquine sensitivity by oncogenic RAS in vitro is context-dependent. Autophagy 10:10, pages 1814-1826.
Read now
Read now
David F. Kashatus & Christopher M. Counter. (2011) Breaking up is hard to do. Small GTPases 2:6, pages 329-333.
Read now
Read now
Vidya Bodempudi, Farnaz Yamoutpoor, Weihong Pan, Arkadiusz Z. Dudek, Tuba Esfandyari, Mark Piedra, Dusica Babovick-Vuksanovic, Richard A. Woo, Victor F. Mautner, Lan Kluwe, D. Wade Clapp, George H. De Vries, Stacey L. Thomas, Andreas Kurtz, Luis F. Parada & Faris Farassati. (2009) Ral Overactivation in Malignant Peripheral Nerve Sheath Tumors. Molecular and Cellular Biology 29:14, pages 3964-3974.
Read now
Read now
Articles from other publishers (84)
Mingxin Cao, Xinming Li, Duc-Anh Trinh, Shingo Yoshimachi, Kota Goto, Natsumi Sakata, Masaharu Ishida, Hideo Ohtsuka, Michiaki Unno, Yuxia Wang, Ryutaro Shirakawa & Hisanori Horiuchi. (2023) Ral GTPase promotes metastasis of pancreatic ductal adenocarcinoma via elevation of TGF-β1 production. Journal of Biological Chemistry 299:6, pages 104754.
Crossref
Crossref
Rahul Agrawal & Kedar Nath Natarajan. 2023. Pancreatic Cancer: Basic Mechanisms and Therapies. Pancreatic Cancer: Basic Mechanisms and Therapies
251
283
.
Halema Al-Farsi, Iman Al-Azwani, Joel A. Malek, Lotfi Chouchane, Arash Rafii & Najeeb M. Halabi. (2022) Discovery of new therapeutic targets in ovarian cancer through identifying significantly non-mutated genes. Journal of Translational Medicine 20:1.
Crossref
Crossref
Lei Fang, Dongmei Li, JuanJuan Yin, Hong Pan, Huihui Ye, Joel Bowman, Brian Capaldo & Kathleen Kelly. (2022) TMPRSS2-ERG promotes the initiation of prostate cancer by suppressing oncogene-induced senescence. Cancer Gene Therapy 29:10, pages 1463-1476.
Crossref
Crossref
Dillon S. Richardson, Jonathan M. Spehar, David T. Han, Prathik A. Chakravarthy & Steven T. Sizemore. (2022) The RAL Enigma: Distinct Roles of RALA and RALB in Cancer. Cells 11:10, pages 1645.
Crossref
Crossref
Juening Kang, Federico La Manna, Francesco Bonollo, Natalie Sampson, Ian L. Alberts, Clemens Mingels, Ali Afshar-Oromieh, George N. Thalmann & Sofia Karkampouna. (2022) Tumor microenvironment mechanisms and bone metastatic disease progression of prostate cancer. Cancer Letters 530, pages 156-169.
Crossref
Crossref
Edith Bonnelye. 2022. Bone Cancer. Bone Cancer
337
355
.
Zachary S. Dovey, Sujit S. Nair, Dimple Chakravarty & Ashutosh K. Tewari. (2021) Racial disparity in prostate cancer in the African American population with actionable ideas and novel immunotherapies. Cancer Reports 4:5.
Crossref
Crossref
Samuel G. Chamberlain, Andrea Gohlke, Arooj Shafiq, Iolo J. SquiresDarerca Owen & Helen R. Mott. (2021) Calmodulin extracts the Ras family protein RalA from lipid bilayers by engagement with two membrane-targeting motifs. Proceedings of the National Academy of Sciences 118:36.
Crossref
Crossref
Lisa H. Apken & Andrea Oeckinghaus. 2021. Signal Transduction in Cancer and Immunity. Signal Transduction in Cancer and Immunity
21
105
.
Htoo Zarni Oo, Roland Seiler, Peter C. Black & Mads Daugaard. (2020) Post-translational modifications in bladder cancer: Expanding the tumor target repertoire. Urologic Oncology: Seminars and Original Investigations 38:12, pages 858-866.
Crossref
Crossref
Hajrah Khawaja, Andrew Campbell, Jamie Z. Roberts, Arman Javadi, Paul O’Reilly, Darragh McArt, Wendy L. Allen, Joanna Majkut, Markus Rehm, Alberto Bardelli, Federica Di Nicolantonio, Christopher J. Scott, Richard Kennedy, Nicolas Vitale, Timothy Harrison, Owen J. Sansom, Daniel B. Longley, Emma Evergren & Sandra Van Schaeybroeck. (2020) RALB GTPase: a critical regulator of DR5 expression and TRAIL sensitivity in KRAS mutant colorectal cancer. Cell Death & Disease 11:10.
Crossref
Crossref
Qing Yang, Chuandong Lang, Zhengquan Wu, Yuhu Dai, Shaofu He, Wei Guo, Shuai Huang, Hong Du, Dong Ren & Xinsheng Peng. (2019) MAZ promotes prostate cancer bone metastasis through transcriptionally activating the KRas-dependent RalGEFs pathway. Journal of Experimental & Clinical Cancer Research 38:1.
Crossref
Crossref
Marcel Seibold, Thorsten Stühmer, Nadine Kremer, Anja Mottok, Claus-Jürgen Scholz, Andreas Schlosser, Ellen Leich, Ulrike Holzgrabe, Daniela Brünnert, Santiago Barrio, K. Martin Kortüm, Antonio G. Solimando, Manik Chatterjee, Hermann Einsele, Andreas Rosenwald, Ralf C. Bargou & Torsten Steinbrunn. (2019) RAL GTPases mediate multiple myeloma cell survival and are activated independently of oncogenic RAS. Haematologica 105:9, pages 2316-2326.
Crossref
Crossref
Lechen Li, Amir H. Ameri, Simeng Wang, Keith H. Jansson, Orla M. Casey, Qi Yang, Michael L. Beshiri, Lei Fang, Ross G. Lake, Supreet Agarwal, Aian N. Alilin, Wanhai Xu, JuanJuan Yin & Kathleen Kelly. (2019) EGR1 regulates angiogenic and osteoclastogenic factors in prostate cancer and promotes metastasis. Oncogene 38:35, pages 6241-6255.
Crossref
Crossref
Masayuki Uegaki, Yuki Kita, Ryutaro Shirakawa, Yuki Teramoto, Yuki Kamiyama, Ryoichi Saito, Takeshi Yoshikawa, Hiromasa Sakamoto, Takayuki Goto, Shusuke Akamatsu, Toshinari Yamasaki, Takahiro Inoue, Akira Suzuki, Hisanori Horiuchi, Osamu Ogawa & Takashi Kobayashi. (2019) Downregulation of RalGTPase-activating protein promotes invasion of prostatic epithelial cells and progression from intraepithelial neoplasia to cancer during prostate carcinogenesis. Carcinogenesis.
Crossref
Crossref
Wei-Yu Chen, Tao Zeng, Yu-Chng Wen, Hsiu-Lien Yeh, Kuo-Ching Jiang, Wei-Hao Chen, Qingfu Zhang, Jiaoti Huang & Yen-Nien Liu. (2019) Androgen deprivation-induced ZBTB46-PTGS1 signaling promotes neuroendocrine differentiation of prostate cancer. Cancer Letters 440-441, pages 35-46.
Crossref
Crossref
Yuan-Chin Tsai, Tao Zeng, Wassim Abou-Kheir, Hsiu-Lien Yeh, Juan Juan Yin, Yi-Chao Lee, Wei-Yu Chen & Yen-Nien Liu. (2018) Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer. Molecular Cancer 17:1.
Crossref
Crossref
Hongjiao Liu, Xiaomian Lin, Tao Huang, Li Song, Cairong Zhu, Hongmin Ma, Tianzhu Long, Huixuan Zeng, Rongzhen Li, Heng Wang, Yishan Huang, Liankuai Chen & Xiaoping Wu. (2018) A short peptide reverses the aggressive phenotype of prostate cancer cells. European Journal of Pharmacology 838, pages 129-137.
Crossref
Crossref
Kendra A. Williams, Minnkyong Lee, Jean M. Winter, Derek E. Gildea, Carla Calagua, Natasha L. Curry, Jens Lichtenberg, Huihui Ye & Nigel P.S. Crawford. (2018)
Prostate cancer susceptibility gene
HIST1H1A
is a modulator of androgen receptor signaling and epithelial to mesenchymal transition
. Oncotarget 9:47, pages 28532-28546.
Crossref
Crossref
Yvona Ward, Ross Lake, Farhoud Faraji, Jamie Sperger, Philip Martin, Cameron Gilliard, Kimberly P. Ku, Tamara Rodems, David Niles, Heather Tillman, JuanJuan Yin, Kent Hunter, Adam G. Sowalsky, Joshua Lang & Kathleen Kelly. (2018) Platelets Promote Metastasis via Binding Tumor CD97 Leading to Bidirectional Signaling that Coordinates Transendothelial Migration. Cell Reports 23:3, pages 808-822.
Crossref
Crossref
Chao Yan & Dan Theodorescu. (2017) RAL GTPases: Biology and Potential as Therapeutic Targets in Cancer. Pharmacological Reviews 70:1, pages 1-11.
Crossref
Crossref
Sarah R. Pollock & David F. Kashatus. 2018. Encyclopedia of Signaling Molecules. Encyclopedia of Signaling Molecules
4424
4433
.
Liwei Lang, Chloe Shay, Xiangdong Zhao & Yong Teng. (2017) Combined targeting of Arf1 and Ras potentiates anticancer activity for prostate cancer therapeutics. Journal of Experimental & Clinical Cancer Research 36:1.
Crossref
Crossref
Adel Rezaei Moghadam, Elham Patrad, Elham Tafsiri, Warner Peng, Benjamin Fangman, Timothy J Pluard, Anthony Accurso, Michael Salacz, Kushal Shah, Brandon Ricke, Danse Bi, Kyle Kimura, Leland Graves, Marzieh Khajoie Najad, Roya Dolatkhah, Zohreh Sanaat, Mina Yazdi, Naeimeh Tavakolinia, Mohammad Mazani, Mojtaba Amani, Saeid Ghavami, Robyn Gartell, Colleen Reilly, Zaid Naima, Tuba Esfandyari & Faris Farassati. (2017) Ral signaling pathway in health and cancer. Cancer Medicine 6:12, pages 2998-3013.
Crossref
Crossref
W-Y Chen, Y-C Tsai, M K Siu, H-L Yeh, C-L Chen, J J Yin, J Huang & Y-N Liu. (2017) Inhibition of the androgen receptor induces a novel tumor promoter, ZBTB46, for prostate cancer metastasis. Oncogene 36:45, pages 6213-6224.
Crossref
Crossref
M K Siu, W-Y Chen, H-Y Tsai, H-Y Chen, J J Yin, C-L Chen, Y-C Tsai & Y-N Liu. (2017) TCF7 is suppressed by the androgen receptor via microRNA-1-mediated downregulation and is involved in the development of resistance to androgen deprivation in prostate cancer. Prostate Cancer and Prostatic Diseases 20:2, pages 172-178.
Crossref
Crossref
Yuan-Chin Tsai, Wei-Yu Chen, Man Kit Siu, Hong-Yuan Tsai, Juan Juan Yin, Jiaoti Huang & Yen-Nien Liu. (2017) Epidermal growth factor receptor signaling promotes metastatic prostate cancer through microRNA-96-mediated downregulation of the tumor suppressor ETV6. Cancer Letters 384, pages 1-8.
Crossref
Crossref
M-K Siu, F Suau, W-Y Chen, Y-C Tsai, H-Y Tsai, H-L Yeh & Y-N Liu. (2016) KLF4 functions as an activator of the androgen receptor through reciprocal feedback. Oncogenesis 5:12, pages e282-e282.
Crossref
Crossref
Chao Yan, Dan Theodorescu, Bettina Miller, Amit Kumar, Vijay Kumar, David Ross & Michael F. Wempe. (2016) Synthesis of novel Ral inhibitors: An in vitro and in vivo study. Bioorganic & Medicinal Chemistry Letters 26:23, pages 5815-5818.
Crossref
Crossref
Takashi Kobayashi. (2016) Understanding the biology of urothelial cancer metastasis. Asian Journal of Urology 3:4, pages 211-222.
Crossref
Crossref
Jitian Li, Liping Dai, Ningjing Lei, Mengtao Xing, Pei Li, Chenglin Luo, Carlos A. Casiano & Jian-Ying Zhang. (2016) Evaluation and characterization of anti-RalA autoantibody as a potential serum biomarker in human prostate cancer. Oncotarget 7:28, pages 43546-43556.
Crossref
Crossref
CHEN CHEN, HONG SHEN, LI-GUO ZHANG, JIAN LIU, XIAO-GE CAO, AN-LIANG YAO, SHAO-SAN KANG, WEI-XING GAO, HUI HAN, FENG-HONG CAO & ZHI-GUO LI. (2016) Construction and analysis of protein-protein interaction networks based on proteomics data of prostate cancer. International Journal of Molecular Medicine 37:6, pages 1576-1586.
Crossref
Crossref
Man Kit Siu, Wei-Yu Chen, Hong-Yuan Tsai, Hsiu-Lien Yeh, Juan Juan Yin, Shih-Yang Liu & Yen-Nien Liu. (2016) Androgen receptor regulates SRC expression through microRNA-203. Oncotarget 7:18, pages 25726-25741.
Crossref
Crossref
Jinlu Dai, Janine Hensel, Ning Wang, Marianna Kruithof-de Julio & Yusuke Shiozawa. (2016) Mouse models for studying prostate cancer bone metastasis. BoneKEy Reports 5.
Crossref
Crossref
Sarah R. Pollock & David F. Kashatus. 2016. Encyclopedia of Signaling Molecules. Encyclopedia of Signaling Molecules
1
10
.
Z Wang, Y Zhou, X Hu, W Chen, X Lin, L Sun, X Xu, W Hong & T Wang. (2015) RILP suppresses invasion of breast cancer cells by modulating the activity of RalA through interaction with RalGDS. Cell Death & Disease 6:10, pages e1923-e1923.
Crossref
Crossref
M K Siu, Y-C Tsai, Y-S Chang, J J Yin, F Suau, W-Y Chen & Y-N Liu. (2014) Transforming growth factor-β promotes prostate bone metastasis through induction of microRNA-96 and activation of the mTOR pathway. Oncogene 34:36, pages 4767-4776.
Crossref
Crossref
Yung-Sheng Chang, Wei-Yu Chen, Juan Juan Yin, Heather Sheppard-Tillman, Jiaoti Huang & Yen-Nien Liu. (2015) EGF Receptor Promotes Prostate Cancer Bone Metastasis by Downregulating miR-1 and Activating TWIST1. Cancer Research 75:15, pages 3077-3086.
Crossref
Crossref
R. Shirakawa & H. Horiuchi. (2015) Ral GTPases: crucial mediators of exocytosis and tumourigenesis. Journal of Biochemistry 157:5, pages 285-299.
Crossref
Crossref
Sunny Guin & Dan Theodorescu. (2015) The RAS-RAL axis in cancer: evidence for mutation-specific selectivity in non-small cell lung cancer. Acta Pharmacologica Sinica 36:3, pages 291-297.
Crossref
Crossref
Wei-Yu Chen, Shih-Yang Liu, Yung-Sheng Chang, Juan Juan Yin, Hsiu-lien Yeh, Tarek H. Mouhieddine, Ola Hadadeh, Wassim Abou-Kheir & Yen-Nien Liu. (2014) MicroRNA-34a regulates WNT/TCF7 signaling and inhibits bone metastasis in Ras-activated prostate cancer. Oncotarget 6:1, pages 441-457.
Crossref
Crossref
Leanna R. Gentry, Timothy D. Martin, David J. Reiner & Channing J. Der. (2014) Ral small GTPase signaling and oncogenesis: More than just 15minutes of fame. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1843:12, pages 2976-2988.
Crossref
Crossref
Chao Yan, Degang Liu, Liwei Li, Michael F. Wempe, Sunny Guin, May Khanna, Jeremy Meier, Brenton Hoffman, Charles Owens, Christina L. Wysoczynski, Matthew D. Nitz, William E. Knabe, Mansoor Ahmed, David L. Brautigan, Bryce M. Paschal, Martin A. Schwartz, David N. M. Jones, David Ross, Samy O. Meroueh & Dan Theodorescu. (2014) Discovery and characterization of small molecules that target the GTPase Ral. Nature 515:7527, pages 443-447.
Crossref
Crossref
JuanJuan Yin, Yen-Nien Liu, Heather Tillman, Ben Barrett, Stephen Hewitt, Kris Ylaya, Lei Fang, Ross Lake, Eva Corey, Colm Morrissey, Robert Vessella & Kathleen Kelly. (2014) AR-Regulated TWEAK-FN14 Pathway Promotes Prostate Cancer Bone Metastasis. Cancer Research 74:16, pages 4306-4317.
Crossref
Crossref
Jessica Tome-Garcia, Dan Li, Seda Ghazaryan, Limin Shu & Lizhao Wu. (2014) ERBB2 Increases Metastatic Potentials Specifically in Androgen-Insensitive Prostate Cancer Cells. PLoS ONE 9:6, pages e99525.
Crossref
Crossref
Man Kit Siu, Wassim Abou-Kheir, Juan Juan Yin, Yung-Sheng Chang, Ben Barrett, Florent Suau, Orla Casey, Wei-Yu Chen, Lei Fang, Paul Hynes, Yao-Yu Hsieh, Yen-Nien Liu, Jiaoti Huang & Kathleen Kelly. (2014) Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance. Oncotarget 5:11, pages 3770-3784.
Crossref
Crossref
Brian O. Bodemann & Michael A. White. 2014. Ras Superfamily Small G Proteins: Biology and Mechanisms 1. Ras Superfamily Small G Proteins: Biology and Mechanisms 1
257
279
.
Sunny Guin, Yuanbin Ru, Murry W. Wynes, Rangnath Mishra, Xian Lu, Charles Owens, Anna E. Barόn, Vihas T. Vasu, Fred R. Hirsch, Jeffrey A. Kern & Dan Theodorescu. (2013) Contributions of KRAS and RAL in Non–Small-Cell Lung Cancer Growth and Progression. Journal of Thoracic Oncology 8:12, pages 1492-1501.
Crossref
Crossref
David F. Kashatus. (2013) Ral GTPases in tumorigenesis: Emerging from the shadows. Experimental Cell Research 319:15, pages 2337-2342.
Crossref
Crossref
Qingxin Liu, Mike R. Russell, Kristina Shahriari, Danielle L. Jernigan, Mercedes I. Lioni, Fernando U. Garcia & Alessandro Fatatis. (2013) Interleukin-1β Promotes Skeletal Colonization and Progression of Metastatic Prostate Cancer Cells with Neuroendocrine Features. Cancer Research 73:11, pages 3297-3305.
Crossref
Crossref
Z Li, Y Zhang, W J Kim & Y Daaka. (2012) PGE2 promotes renal carcinoma cell invasion through activated RalA. Oncogene 32:11, pages 1408-1415.
Crossref
Crossref
Y-N Liu, J J Yin, W Abou-Kheir, P G Hynes, O M Casey, L Fang, M Yi, R M Stephens, V Seng, H Sheppard-Tillman, P Martin & K Kelly. (2012) MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms. Oncogene 32:3, pages 296-306.
Crossref
Crossref
Jonathan M. Cooper, Brian O. Bodemann & Michael A. White. 2013. Inhibitors of the Ras superfamily G-proteins, Part B. Inhibitors of the Ras superfamily G-proteins, Part B
137
156
.
Steven C. Smith, Alexander S. Baras, Charles R. Owens, Garrett Dancik & Dan Theodorescu. (2012) Transcriptional Signatures of Ral GTPase Are Associated with Aggressive Clinicopathologic Characteristics in Human Cancer. Cancer Research 72:14, pages 3480-3491.
Crossref
Crossref
David J. Mulholland, Naoko Kobayashi, Marcus Ruscetti, Allen Zhi, Linh M. Tran, Jiaoti Huang, Martin Gleave & Hong Wu. (2012)
Pten
Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor Cells
. Cancer Research 72:7, pages 1878-1889.
Crossref
Crossref
KETAO JIN, WEILI GAO, YANYAN LU, HUANRONG LAN, LISONG TENG & FEILIN CAO. (2012) Mechanisms regulating colorectal cancer cell metastasis into liver (Review). Oncology Letters 3:1, pages 11-15.
Crossref
Crossref
Yvona Ward, Ross Lake, Juan Juan Yin, Christopher D. Heger, Mark Raffeld, Paul K. Goldsmith, Maria Merino & Kathleen Kelly. (2011) LPA Receptor Heterodimerizes with CD97 to Amplify LPA-Initiated RHO-Dependent Signaling and Invasion in Prostate Cancer Cells. Cancer Research 71:23, pages 7301-7311.
Crossref
Crossref
Antonio T Baines, Dapeng Xu & Channing J Der. (2011) Inhibition of Ras for cancer treatment: the search continues. Future Medicinal Chemistry 3:14, pages 1787-1808.
Crossref
Crossref
Masakazu Hamada, Tetsuei Miki, Soichi Iwai, Hidetaka Shimizu & Yoshiaki Yura. (2010) Involvement of RhoA and RalB in geranylgeranyltransferase I inhibitor-mediated inhibition of proliferation and migration of human oral squamous cell carcinoma cells. Cancer Chemotherapy and Pharmacology 68:3, pages 559-569.
Crossref
Crossref
Philip Martin, Yen-Nien Liu, Rachel Pierce, Wassim Abou-Kheir, Orla Casey, Victoria Seng, Daniel Camacho, R. Mark Simpson & Kathleen Kelly. (2011) Prostate Epithelial Pten/TP53 Loss Leads to Transformation of Multipotential Progenitors and Epithelial to Mesenchymal Transition. The American Journal of Pathology 179:1, pages 422-435.
Crossref
Crossref
A. V. Knizhnik, O. V. Kovaleva, K. K. Laktionov, V. V. Mochalnikova, A. V. Komelkov, E. M. Tchevkina & I. B. Zborovskaya. (2011) Arf6, RalA, and BIRC5 protein expression in nonsmall cell lung cancer. Molecular Biology 45:2, pages 275-282.
Crossref
Crossref
Olga Zolochevska & Marxa L. Figueiredo. (2011) Cell-cycle regulators cdk2ap1 and bicalutamide suppress malignant biological interactions between prostate cancer and bone cells. The Prostate 71:4, pages 353-367.
Crossref
Crossref
Megan N. Thobe, Robert J. Clark, Russell O. Bainer, Sandip M. Prasad & Carrie W. Rinker-Schaeffer. (2011) From Prostate to Bone: Key Players in Prostate Cancer Bone Metastasis. Cancers 3:1, pages 478-493.
Crossref
Crossref
Timothy D. Martin, Jonathan C. Samuel, Elizabeth D. Routh, Channing J. Der & Jen Jen Yeh. (2011) Activation and Involvement of Ral GTPases in Colorectal Cancer. Cancer Research 71:1, pages 206-215.
Crossref
Crossref
Suzanne A. Eccles. 2011. Tumor Models in Cancer Research. Tumor Models in Cancer Research
447
495
.
Zhong Wu, Charles Owens, Nidhi Chandra, Kay Popovic, Mark Conaway & Dan Theodorescu. (2010) RalBP1 Is Necessary for Metastasis of Human Cancer Cell Lines. Neoplasia 12:12, pages 1003-1012.
Crossref
Crossref
Dominico Vigil, Jacqueline Cherfils, Kent L. Rossman & Channing J. Der. (2010) Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?. Nature Reviews Cancer 10:12, pages 842-857.
Crossref
Crossref
Elisa Ferro & Lorenza Trabalzini. (2010) RalGDS family members couple Ras to Ral signalling and that's not all. Cellular Signalling 22:12, pages 1804-1810.
Crossref
Crossref
Juan Juan Yin, Luhua Zhang, Jeeva Munasinghe, R. Ilona Linnoila & Kathleen Kelly. (2010) Cediranib/AZD2171 Inhibits Bone and Brain Metastasis in a Preclinical Model of Advanced Prostate Cancer. Cancer Research 70:21, pages 8662-8673.
Crossref
Crossref
Hong Wang, Charles Owens, Nidhi Chandra, Mark R. Conaway, David L. Brautigan & Dan Theodorescu. (2010) Phosphorylation of RalB Is Important for Bladder Cancer Cell Growth and Metastasis. Cancer Research 70:21, pages 8760-8769.
Crossref
Crossref
Dominico Vigil, Timothy D. Martin, Falina Williams, Jen Jen Yeh, Sharon L. Campbell & Channing J. Der. (2010) Aberrant Overexpression of the Rgl2 Ral Small GTPase-specific Guanine Nucleotide Exchange Factor Promotes Pancreatic Cancer Growth through Ral-dependent and Ral-independent Mechanisms. Journal of Biological Chemistry 285:45, pages 34729-34740.
Crossref
Crossref
P A Zipfel, D C Brady, D F Kashatus, B D Ancrile, D S Tyler & C M Counter. (2010) Ral activation promotes melanomagenesis. Oncogene 29:34, pages 4859-4864.
Crossref
Crossref
P J Mishra, L Ha, J Rieker, E V Sviderskaya, D C Bennett, M D Oberst, K Kelly & G Merlino. (2010) Dissection of RAS downstream pathways in melanomagenesis: a role for Ral in transformation. Oncogene 29:16, pages 2449-2456.
Crossref
Crossref
Jose Luis Luque-García, Jorge Luis Martínez-Torrecuadrada, Carolina Epifano, Marta Cañamero, Ingrid Babel & J. Ignacio Casal. (2010) Differential protein expression on the cell surface of colorectal cancer cells associated to tumor metastasis. PROTEOMICS 10:5, pages 940-952.
Crossref
Crossref
Jen Jen Yeh, James P. Madigan, Paul M. Campbell, Patrick J. Roberts, Lanika DeGraffenreid & Channing J. Der. 2010. Handbook of Cell Signaling. Handbook of Cell Signaling
2837
2857
.
Wen-Sheng Wu & Jia-Ru Wu. 2010. Signal Transduction in Cancer Metastasis. Signal Transduction in Cancer Metastasis
1
8
.
Ryutaro Shirakawa, Shuya Fukai, Mitsunori Kawato, Tomohito Higashi, Hirokazu Kondo, Tomoyuki Ikeda, Ei Nakayama, Katsuya Okawa, Osamu Nureki, Takeshi Kimura, Toru Kita & Hisanori Horiuchi. (2009) Tuberous Sclerosis Tumor Suppressor Complex-like Complexes Act as GTPase-activating Proteins for Ral GTPases. Journal of Biological Chemistry 284:32, pages 21580-21588.
Crossref
Crossref
Timothy T. Li, Mistre Alemayehu, Adel I. Aziziyeh, Cynthia Pape, Macarena Pampillo, Lynne-Marie Postovit, Gordon B. Mills, Andy V. Babwah & Moshmi Bhattacharya. (2009) β-Arrestin/Ral Signaling Regulates Lysophosphatidic Acid–Mediated Migration and Invasion of Human Breast Tumor Cells. Molecular Cancer Research 7:7, pages 1064-1077.
Crossref
Crossref
Juan JuanYin, Kirsten Tracy, Luhua Zhang, Jeeva Munasinghe, Erik Shapiro, Alan Koretsky & Kathleen Kelly. (2009) Noninvasive imaging of the functional effects of anti-VEGF therapy on tumor cell extravasation and regional blood volume in an experimental brain metastasis model. Clinical & Experimental Metastasis 26:5, pages 403-414.
Crossref
Crossref
Steven Christopher Smith & Dan Theodorescu. (2009) The Ral GTPase pathway in metastatic bladder cancer: Key mediator and therapeutic target. Urologic Oncology: Seminars and Original Investigations 27:1, pages 42-47.
Crossref
Crossref
Michael D Oberst, Stacey J Beberman, Liu Zhao, Juan Juan Yin, Yvona Ward & Kathleen Kelly. (2008) TDAG51 is an ERK signaling target that opposes ERK-mediated HME16C mammary epithelial cell transformation. BMC Cancer 8:1.
Crossref
Crossref
Ira Skvortsova, Sergej Skvortsov, Taras Stasyk, Uma Raju, Bela-Andre Popper, Bernhard Schiestl, Elisabeth von Guggenberg, Andreas Neher, Guenther K. Bonn, Lukas A. Huber & Peter Lukas. (2008) Intracellular signaling pathways regulating radioresistance of human prostate carcinoma cells. PROTEOMICS 8:21, pages 4521-4533.
Crossref
Crossref
Brian O. Bodemann & Michael A. White. (2008) Ral GTPases and cancer: linchpin support of the tumorigenic platform. Nature Reviews Cancer 8:2, pages 133-140.
Crossref
Crossref